Craig Greathouse
Directeur Administratif chez MVB FINANCIAL CORP.
Fortune : 403 706 $ au 31/05/2024
Postes actifs de Craig Greathouse
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MVB FINANCIAL CORP. | Directeur Administratif | 27/01/2022 | - |
| Responsable des Ressources Humaines | 10/05/2018 | 27/01/2022 |
Historique de carrière de Craig Greathouse
Anciens postes connus de Craig Greathouse
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Mylan, Inc.
 Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Responsable des Ressources Humaines | 01/01/2010 | 01/01/2018 |
| United Way of Monongalia & Preston Counties | Directeur/Membre du Conseil | - | - |
| Corporate Officer/Principal | - | - |
Formation de Craig Greathouse
| West Virginia University | Undergraduate Degree |
| University of South Carolina | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Human Resources Officer | 2 |
| Chief Administrative Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MVB FINANCIAL CORP. | Finance |
| Entreprise privées | 2 |
|---|---|
| United Way of Monongalia & Preston Counties | |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
- Bourse
- Insiders
- Craig Greathouse
- Expérience
